Nationwide Inventory of Risk Factors for Retinopathy of Prematurity in the Netherlands

• Published in: The Journal of pediatrics Vol. 164; no. 3; pp. 494 - 498.e1
• Main Authors: van Sorge, Arlette J., MD, Termote, Jacqueline U.M., PhD, Kerkhoff, Frank T., PhD, van Rijn, Laurentius J., PhD, Simonsz, Huibert J., PhD, Peer, Petronella G.M., PhD, Schalij-Delfos, Nicoline E., PhD
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.2014
• Subjects: Administration, Inhalation; Birth Weight; Bronchodilator Agents - administration & dosage; Bronchodilator Agents - adverse effects; Databases, Factual; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Length of Stay - statistics & numerical data; Logistic Models; Male; Netherlands - epidemiology; Nitric Oxide - administration & dosage; Nitric Oxide - adverse effects; Pediatrics; Prospective Studies; Respiration, Artificial - statistics & numerical data; Retinopathy of Prematurity - epidemiology; Risk Factors; Netherlands; Retinopathy of prematurity; Insulin-like growth factor-1; NICU; Netherlands Retinopathy of Prematurity; Gestational age; BW; DOB; Inhaled nitric oxide; Parts per million; GA; Date of birth; Vascular endothelial growth factor; Length of stay; NEDROP; VEGF; IGF-1; iNO; ppm; Chronic lung disease; LOS; ROP; Neonatal intensive care unit; BPD; Bronchopulmonary dysplasia; Birth weight; CLD
• ISSN: 0022-3476; 1097-6833
• DOI: 10.1016/j.jpeds.2013.11.015

Objectives To study the incidence and risk factors for retinopathy of prematurity (ROP) in the Netherlands. Study design Prospective, approximating population-based study that included infants with gestational age (GA) <32 weeks and/or birth weight (BW) <1500 g born in 2009. Pediatricians and ophthalmologists of all hospitals involved in care for premature infants reported data that were matched with the national perinatal database for risk factor analysis. Results Of 1380 infants, median GA 29.8 weeks (IQR 28.1-31.1) and median BW 1260 g (IQR 1020-1500), ROP developed in 21.9%. Logistic regression identified GA and BW as risk factors for ROP ( P < .001). After adjustment for GA and BW, additional risk factors were inhaled nitric oxide (iNO; OR 2.6, 95% CI 1.1-6.2, P = .03), stay at a neonatal intensive care unit >28 days (OR 1.6, 95% CI 1.1-2.6, P = .03), and artificial ventilation >7 days (OR 1.6, 95% CI 1.1-2.5, P = .02). Prenatal glucocorticoids (OR 0.6, 95% CI 0.4-0.8, P < .001) and female sex (OR 0.7, 95% CI 0.5-0.99, P = .04) showed a lesser incidence of ROP. iNO remained significant after correction for all significant factors (OR 2.6, 95% CI 1.1-6.2, P = .03). Conclusion In addition to established risk factors (GA, BW, stay at a neonatal intensive care unit >28 days, and artificial ventilation >7 days), treatment with iNO as risk factor for ROP is a novel finding.